One World Pharma Inc. to Present at the LD Micro 12th Annual Main Event December 10, 2019
LAS VEGAS, NV, Dec. 4, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – One World Pharma Inc. (OTC: OWPC), “OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, today announced that Craig Ellins, CEO, will be a featured presenter at the LD Micro Main Event on December 10, 2019 at 4:20PM, at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Management will also be available for one-on-one meetings. Mr. Ellins is expected to demonstrate to attendees how OWP’s unique business model is a potential hedge against issues that have beset other international cannabis companies and to discuss imminent changes for the international cannabis supply chain. OWP has a different business model than most other cannabis companies as its partnership with the local indigenous people helps them cultivate and create their own cannabis and hemp economies. One World Pharma is also pioneering a unique “Futures Program” which looks to capitalize on the commoditization of cannabis by providing large scale manufacturers with reliable, high quality cannabis ingredients at predictable prices. The company has already received unique permissions to grow THC and CBD in Colombia. For those interested in attending or for registered attendees who wish to request meetings, please contact David Scher at firstname.lastname@example.org or visit www.ldmicro.com for more information.
About One World PharmaOne World Pharma Inc. is the U.S. parent company of One World Pharma S.A.S, a fully licensed cannabis and hemp producer with offices and operations in Bogota and Popayan, Colombia. One World Pharma planted its first crop of cannabis in 2018 at its cultivation site in Popayan, Colombia, for research purposes and expects to begin harvesting commercially in the second quarter of 2020. The company intends to supply the highest quality cannabis and hemp derivatives in crude oil, distillate and isolate forms with industrial-scale production to serve global cannabis demand. Its products will be produced and tested to GMP standards.Please note that from time to time the Company may post new information at its website: www.OneWorldPharma.com
One World Pharma Company Contact:
Mimi TekabeOne World Pharma Inc.
One World Pharma Investor Relations & Financial Media:
Toll-Free: (888) 216-3595
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, the demand for the Company’s products, governmental regulation of the cannabis industry, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company’s Current Report on 8-K filed with the Securities and Exchange Commission on July 12, 2019, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.